Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. NERLYNX
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

NERLYNX

Medicine - Posted on May 30 2023
Active substance (DCI)
  • nératinib
history (2)
  • 5/24/23

    NERLYNX (neratinib) - Breast cancer

    Inclusion. Key points Unfavourable opinion for reimbursement “in the extended adjuvant treatment of adult patients with earl...
    CAV :
    54321
    icône flèche
  • 6/24/20

    NERLYNX

    First assessment. Unfavourable opinion for reimbursement in the extended adjuvant treatment of adult patients with early-sta...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L01EH02
Manufacturer
PIERRE FABRE MÉDICAMENT
Presentation

NERLYNX 40 mg, comprimé pelliculé
1 flacon de 180 comprimés pelliculés (CIP : 34009 301 944 9 2)

All our publications
    Breast cancers Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
5Wat2wc83kLMU1dV